Antimicrobial chemotherapy of chlamydial infection: where next?

scientific article published on October 1986

Antimicrobial chemotherapy of chlamydial infection: where next? is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1007/BF02017703
P698PubMed publication ID3536500

P2093author name stringG L Ridgway
P2860cites workSingle dose ciprofloxacin for treating gonococcal infections in men.Q33582910
Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men.Q33583148
In vitro activity of clavulanic acid, amoxicillin, and ticarcillin against Chlamydia trachomatisQ35650054
Comparative in vitro activity of RU 28965 against Chlamydia trachomatisQ37902524
In-vitro and in-vivo activity of parenterally administered beta-lactam antibiotics against Chlamydia trachomatisQ37903163
Partial efficacy of clindamycin against Chlamydia trachomatis in men with nongonococcal urethritisQ37903166
Unsuccessful treatment of non-gonococcal urethritis with rosoxacin provides information on the aetiology of the diseaseQ37904698
Activity of the newer quinolones against Chlamydia trachomatisQ37905259
The activity of ciprofloxacin and other 4-quinolones againstChlamydia trachomatis andMycoplasmas in vitroQ37905501
Failure of beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitisQ37906518
In vitro activity of rifamycins alone and in combination with other antibiotics against Chlamydia trachomatis.Q37906901
Rosaramicin and tetracycline in the treatment of non-gonococcal urethritis. A comparison of clinical and microbiological results.Q37908189
Treatment of nongonococcal urethritis with rifampicin as a means of defining the role of Ureaplasma urealyticumQ37910896
The antimicrobial susceptibility of Chlamydia trachomatis in cell cultureQ37911356
A method for testing the antibiotic susceptibility of Chlamydia trachomatis in a cell culture systemQ37912200
In Vitro Susceptibility of Ureaplasma urealyticum to RosaramicinQ40620739
In vitro activity of amifloxacin against Chlamydia trachomatis and Ureaplasma urealyticumQ43440685
Antichlamydial activity of quinolone carboxylic acidsQ43441012
In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatisQ43441418
In vitro activity of norfloxacin againstChlamydia trachomatisQ43442073
A new Micromonospora-produced macrolide antibiotic, rosamicinQ54655337
P433issue5
P921main subjectchemotherapyQ974135
P304page(s)550-553
P577publication date1986-10-01
P1433published inEuropean journal of clinical microbiologyQ27710821
P1476titleAntimicrobial chemotherapy of chlamydial infection: where next?
P478volume5

Reverse relations

cites work (P2860)
Q37894802Azithromycin vs doxycycline in the treatment of non-gonococcal urethritis
Q38657865Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).
Q28359405In vitro and in vivo antibacterial activities of BMY 40062, a new fluoronaphthyridone
Q36711581Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.
Q39658490Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Q34674654Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Q35563856Rapid determination of MICs of 15 antichlamydial agents by using an enzyme immunoassay (Chlamydiazyme).
Q37900922Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms

Search more.